Levels of several mediators such as TGF-βs, vascular endothelial growth factor, CTGF, and monocyte chemoattractant protein-1 are reportedly higher in the AH of POAG, XFG, and neovascular glaucoma patients11–15. This evidence concerns the gene CCN2 and neovascular glaucoma.